CN107998186A - 一种针对抑郁症的组合物 - Google Patents
一种针对抑郁症的组合物 Download PDFInfo
- Publication number
- CN107998186A CN107998186A CN201711372468.3A CN201711372468A CN107998186A CN 107998186 A CN107998186 A CN 107998186A CN 201711372468 A CN201711372468 A CN 201711372468A CN 107998186 A CN107998186 A CN 107998186A
- Authority
- CN
- China
- Prior art keywords
- parts
- depression
- polygala
- oyster
- blue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 18
- 241000237502 Ostreidae Species 0.000 claims abstract description 20
- 241000208966 Polygala Species 0.000 claims abstract description 20
- 241000923606 Schistes Species 0.000 claims abstract description 20
- 229910001919 chlorite Inorganic materials 0.000 claims abstract description 20
- 229910052619 chlorite group Inorganic materials 0.000 claims abstract description 20
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 claims abstract description 20
- 235000020636 oyster Nutrition 0.000 claims abstract description 20
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 19
- 244000046146 Pueraria lobata Species 0.000 claims description 17
- 241000234435 Lilium Species 0.000 claims description 10
- 241001247821 Ziziphus Species 0.000 claims description 10
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 8
- 244000170916 Paeonia officinalis Species 0.000 claims description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 2
- 241000219780 Pueraria Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 38
- 239000003814 drug Substances 0.000 abstract description 14
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 abstract description 7
- 208000019901 Anxiety disease Diseases 0.000 abstract description 7
- 210000004185 liver Anatomy 0.000 abstract description 7
- 210000000952 spleen Anatomy 0.000 abstract description 7
- 208000011580 syndromic disease Diseases 0.000 abstract description 7
- 239000002994 raw material Substances 0.000 abstract description 6
- 238000005728 strengthening Methods 0.000 abstract description 6
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 5
- 241000219781 Pueraria montana var. lobata Species 0.000 abstract 2
- 230000000994 depressogenic effect Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 206010012239 Delusion Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 231100000868 delusion Toxicity 0.000 description 1
- 230000003001 depressive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000000955 neuroendocrine Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及到医疗领域，具体而言是一种针对抑郁症的组合物，包括太子参、葛根、远志、牡蛎、青礞石和白术，所述太子参30‑50份，葛根20‑30份，远志20‑30份，牡蛎5‑25份，青礞石12‑20份，白术18‑33份。本发明完全采用中药组份，具有抗抑郁、抗焦虑的功能，治疗抑郁症、焦虑症疗效确切、起效快。对人体副作用较之西药降低很多，原料种类少，易于获得，并且无论在预防和/或治疗抑郁症还是在更年期综合症上都具有良好的效果。药物组合物具有疏肝健脾、解郁安神的功效，可有效地抗抑郁，并且价格低廉、易于较大范围地使用。
Description
技术领域
本发明涉及到医疗领域，具体而言是一种针对抑郁症的组合物。
背景技术
迄今，抑郁症的病因并不非常清楚，但可以肯定的是，生物、心理与社会环境诸多方面因素参与了抑郁症的发病过程。生物学因素主要涉及遗传、神经生化、神经内分泌、神经再生等方面；与抑郁症关系密切的心理学易患素质是病前性格特征，如抑郁气质。成年期遭遇应激性的生活事件，是导致出现具有临床意义的抑郁发作的重要触发条件。然而，以上这些因素并不是单独起作用的，强调遗传与环境或应激因素之间的交互作用、以及这种交互作用的出现时点在抑郁症发生过程中具有重要的影响。主要表现为显著而持久的情感低落，抑郁悲观。轻者闷闷不乐、无愉快感、兴趣减退，重者痛不欲生、悲观绝望、度日如年、生不如死。典型患者的抑郁心境有晨重夜轻的节律变化。在心境低落的基础上，患者会出现自我评价降低，产生无用感、无望感、无助感和无价值感，常伴有自责自罪，严重者出现罪恶妄想和疑病妄想，部分患者可出现幻觉。但是现在治疗抑郁的药物大多都是西药，这些西药对于人体神经具有很强的副作用，虽然患者的抑郁情况能够得到一定的缓解，但是副作用太大，患者在白天也会精神不振，精神萎靡，对于神经有强大的抑制作用。
发明内容
为了克服现有的技术存在的上述问题，现特别提出一种对人体副作用小，但是抑郁疗效和西药相当的中药组合物。
为实现上述技术目的，本发明的技术方案如下：
一种针对抑郁症的组合物，其特征在于：包括太子参、葛根、远志、牡蛎、青礞石和白术，所述太子参30-50份，葛根20-30份，远志20-30份，牡蛎5-25份，青礞石12-20份，白术18-33份。
所述太子参35-45份，葛根22-28份，远志22-28份，牡蛎10-20份，青礞石13-17份，白术20-28份。
所述太子参41份，葛根25份，远志23份，牡蛎16份，青礞石16份，白术27份。
还包括白芍、大枣和百合，所述白芍15-20份，大枣15-20份，百合10-15份。
所述白芍15份，大枣17份，百合14份。
本发明的优点在于：
本发明完全采用中药组份，具有抗抑郁、抗焦虑的功能，治疗抑郁症、焦虑症疗效确切、起效快。各个配方之间能够相互配合，发挥效力，而且对人体副作用较之西药降低很多，原料种类少，易于获得，并且无论在预防和/或治疗抑郁症还是在更年期综合症上都具有良好的效果。药物组合物具有疏肝健脾、解郁安神的功效，可有效地抗抑郁，并且价格低廉、易于较大范围地使用。
具体实施方式
实施例1
一种针对抑郁症的组合物包括太子参、葛根、远志、牡蛎、青礞石和白术，所述太子参30-50份，葛根20-30份，远志20-30份，牡蛎5-25份，青礞石12-20份，白术18-33份。本发明完全采用中药组份，具有抗抑郁、抗焦虑的功能，治疗抑郁症、焦虑症疗效确切、起效快。各个配方之间能够相互配合，发挥效力，而且对人体副作用较之西药降低很多，原料种类少，易于获得，并且无论在预防和/或治疗抑郁症还是在更年期综合症上都具有良好的效果。药物组合物具有疏肝健脾、解郁安神的功效，可有效地抗抑郁，并且价格低廉、易于较大范围地使用。
实施例2
一种针对抑郁症的组合物包括太子参、葛根、远志、牡蛎、青礞石和白术，所述太子参35-45份，葛根22-28份，远志22-28份，牡蛎10-20份，青礞石13-17份，白术20-28份。本发明完全采用中药组份，具有抗抑郁、抗焦虑的功能，治疗抑郁症、焦虑症疗效确切、起效快。各个配方之间能够相互配合，发挥效力，而且对人体副作用较之西药降低很多，原料种类少，易于获得，并且无论在预防和/或治疗抑郁症还是在更年期综合症上都具有良好的效果。药物组合物具有疏肝健脾、解郁安神的功效，可有效地抗抑郁，并且价格低廉、易于较大范围地使用。
实施例3
一种针对抑郁症的组合物包括太子参、葛根、远志、牡蛎、青礞石和白术， 所述太子参41份，葛根25份，远志23份，牡蛎16份，青礞石16份，白术27份。本发明完全采用中药组份，具有抗抑郁、抗焦虑的功能，治疗抑郁症、焦虑症疗效确切、起效快。各个配方之间能够相互配合，发挥效力，而且对人体副作用较之西药降低很多，原料种类少，易于获得，并且无论在预防和/或治疗抑郁症还是在更年期综合症上都具有良好的效果。药物组合物具有疏肝健脾、解郁安神的功效，可有效地抗抑郁，并且价格低廉、易于较大范围地使用。
实施例4
一种针对抑郁症的组合物包括太子参、葛根、远志、牡蛎、青礞石和白术，所述太子参30-50份，葛根20-30份，远志20-30份，牡蛎5-25份，青礞石12-20份，白术18-33份。还包括白芍、大枣和百合，所述白芍15-20份，大枣15-20份，百合10-15份。本发明完全采用中药组份，具有抗抑郁、抗焦虑的功能，治疗抑郁症、焦虑症疗效确切、起效快。各个配方之间能够相互配合，发挥效力，而且对人体副作用较之西药降低很多，原料种类少，易于获得，并且无论在预防和/或治疗抑郁症还是在更年期综合症上都具有良好的效果。药物组合物具有疏肝健脾、解郁安神的功效，可有效地抗抑郁，并且价格低廉、易于较大范围地使用。
实施例5
一种针对抑郁症的组合物包括太子参、葛根、远志、牡蛎、青礞石和白术，
所述太子参41份，葛根25份，远志23份，牡蛎16份，青礞石16份，白术27份。还包括白芍、大枣和百合，所述白芍15份，大枣17份，百合14份。本发明完全采用中药组份，具有抗抑郁、抗焦虑的功能，治疗抑郁症、焦虑症疗效确切、起效快。各个配方之间能够相互配合，发挥效力，而且对人体副作用较之西药降低很多，原料种类少，易于获得，并且无论在预防和/或治疗抑郁症还是在更年期综合症上都具有良好的效果。药物组合物具有疏肝健脾、解郁安神的功效，可有效地抗抑郁，并且价格低廉、易于较大范围地使用。
Claims (5)
1.一种针对抑郁症的组合物，其特征在于：包括太子参、葛根、远志、牡蛎、青礞石和白术，所述太子参30-50份，葛根20-30份，远志20-30份，牡蛎5-25份，青礞石12-20份，白术18-33份。
2.根据权利要求1所述的一种针对抑郁症的组合物，其特征在于：所述太子参35-45份，葛根22-28份，远志22-28份，牡蛎10-20份，青礞石13-17份，白术20-28份。
3.根据权利要求2所述的一种针对抑郁症的组合物，其特征在于：所述太子参41份，葛根25份，远志23份，牡蛎16份，青礞石16份，白术27份。
4.根据权利要求1-3任意一项所述的一种针对抑郁症的组合物，其特征在于：还包括白芍、大枣和百合，所述白芍15-20份，大枣15-20份，百合10-15份。
5.根据权利要求4所述的一种针对抑郁症的组合物，其特征在于：所述白芍15份，大枣17份，百合14份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711372468.3A CN107998186A (zh) | 2017-12-19 | 2017-12-19 | 一种针对抑郁症的组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711372468.3A CN107998186A (zh) | 2017-12-19 | 2017-12-19 | 一种针对抑郁症的组合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107998186A true CN107998186A (zh) | 2018-05-08 |
Family
ID=62059682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711372468.3A Withdrawn CN107998186A (zh) | 2017-12-19 | 2017-12-19 | 一种针对抑郁症的组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107998186A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110974917A (zh) * | 2019-11-25 | 2020-04-10 | 垒途智能教科技术研究院江苏有限公司 | 一种具有辅助防治儿童、青少年心理抑郁的作用的复合制剂 |
-
2017
- 2017-12-19 CN CN201711372468.3A patent/CN107998186A/zh not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110974917A (zh) * | 2019-11-25 | 2020-04-10 | 垒途智能教科技术研究院江苏有限公司 | 一种具有辅助防治儿童、青少年心理抑郁的作用的复合制剂 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Oke et al. | Ganoderma lucidum: Unutilized natural medicine and promising future solution to emerging diseases in Africa | |
| AR076607A1 (es) | Composicion acuosa. metodo para producir una preparacion altamente concentrada de inmunoglobulina de uso subcutaneo | |
| Sadek et al. | Harnessing the power of bee venom for therapeutic and regenerative medical applications: an updated review | |
| CN104857545A (zh) | 一种养生保健用香及其制作工艺 | |
| WO2008157791A3 (en) | Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration using isothiazolopyrimidinones | |
| John et al. | Combination effects of curcumin and aqueous extract of Lignosus rhinocerotis mycelium on neurite outgrowth stimulation activity in PC-12 cells | |
| CN107998186A (zh) | 一种针对抑郁症的组合物 | |
| Gryzenhout et al. | Ganoderma: Diversity, ecological significances, and potential applications in industry and allied sectors | |
| CN104224813B (zh) | 一种药物组合物及其制备方法与用途 | |
| EP1684775B1 (de) | Verwendung von extrakten aus pelargonium-spezies | |
| CN104186998A (zh) | 一种畜禽用中药饲料添加剂及其制备方法 | |
| CN108042697A (zh) | 一种针对抑郁症的组合物的制备方法 | |
| KR20160149853A (ko) | 퇴행성 뇌질환 예방 또는 치료용 약학 조성물 | |
| CN1331482C (zh) | 一种治疗乙肝、肝硬化的中药 | |
| Kumar et al. | Possible character of classical therapeutic rhizome of turmeric for the prevention and the executives of novel corona virus | |
| Almuthaybiri et al. | Evaluation of the Effect of Pheophytin A on Electroshock-Induced Seizures in Experimental Animals | |
| JP2018203677A (ja) | プロコラーゲンプロセッシング促進剤 | |
| Gokul et al. | Mushrooms for the brain: A review of the neuroprotective effects of mushroom bioactive compounds | |
| CN106491926A (zh) | 治疗鸡眼的药物 | |
| RU2375922C2 (ru) | Биологически активная добавка к пище | |
| JP6418548B2 (ja) | 末梢神経の脱髄抑制剤 | |
| WO2008055620A2 (de) | Verfahren zum herstellen eines mittels gegen eine infektionskrankheit | |
| CN108728246A (zh) | 一种含天然功效的植物香料 | |
| CN1839942A (zh) | 一种抗流感病毒的中药有效部位及其制备方法 | |
| KR20050059956A (ko) | 흰목이 추출물을 함유하는 치매 예방용 기능성 식품 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180508 |